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Background: It was previously reported in China that two recent large-scale outbreaks of Streptococcus suis
serotype 2 (S. suis 2) infections in human were caused by two highly virulent S. suis 2 strains, from which a novel
genomic island (GEI), associated with disease onset and progression and designated 89 K, was identified. Here, an
avirulent strain, 05HAS68, was isolated from a clinically healthy pig.
Results: By comparing the genomes of this avirulent strain with virulent strains, it was found that massive genomic
rearrangements occurred, resulting in alterations in gene expression that caused enormous single gene gain and
loss. Important virulent genes were lost, such as extracellular protein factor (ef) and suilysin (sly) and larger mutants,
such as muramidase-released protein (mrp). Piglets vaccinated with the avirulent strain, 05HAS68, had increased
TNF-α and IFN-γ levels in the peripheral blood and were fully protected from challenge infection with the most
virulent S. suis 2 strain, 05ZYH33. Transfusion of T cells and plasma from vaccinated pigs resulted in protection of
recipient animals against the 05ZYH33 challenge.
Conclusion: These results suggest that analysis genome of the avirulent strains are instrumental in the
development of vaccines and for the functional characterization of important of genetic determinants.Background
The genus Streptococcus is one of the most diverse
gram-positive pathogen for both humans and livestock.
A few multivalent streptococcal conjugate vaccines have
been introduced and have significantly reduced the inva-
siveness of these pathogens. Recently however, there are
some strains that have become resistant to these new
types of vaccine [1]. S. suis is one of the most serious
pathogens, causing meningitis, septicemia, arthritis and
other diseases in pigs [2] and is responsible for substan-
tial economic losses in the swine industry. S. suis has
also been associated with meningitis, endocarditis and* Correspondence: wj6373@hotmail.com; tjq85@hotmail.com
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based on capsular antigens, have been identified. Serotype
2 is considered the most virulent and is frequently isolated
from both swine and humans [4]. The mechanisms in-
volved in the pathogensis and virulence of serotype 2
(S.suis 2) are poorly understood. S. suis 2, followed closely
by S. pneumonia, has been found to have the greatest
number of gene gain and loss under positive selection
pressure [5]. Prevention and control of diseases caused by
this pathogen is hampered by the lack of an effective vac-
cine that generates a protective response.
Several candidate vaccines have been investigated. First,
vaccines against bacteria that cause disease mainly by pro-
duction of virulence protein factors were considered such
as suilysin (SLY), muramidase-released protein (MRP) and
extracellular protein factor (EF). These proteins have been
shown to protect pigs from homologues and heterologous
serotype 2 strains; however, a substantial number ofle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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these proteins [6, 7]. Second, capsule polysaccharide is an-
other type of virulence factor found in S. suis. However, a
vaccine based on capsular material was unsatisfactory
because polysaccharide and lipoligosaccharide antigens
are similarly variable and are unlikely to provide long-
lived immunity, since they are T-cell-independent antigens
that are incapable of stimulating immunological memory
[8]. Third, some immunity protection has been reported
using killed whole cells; however the heat-killed bacteria
are rapidly eliminated by chemokine-activated phagocytes
and are unable to activate protective long-lasting or im-
munological memory responses [9]. S.suis vaccines, either
polysaccharide, conjugate or killed bacteria, are currently
being tested in trials in order to overcome the rise in
worldwide antibiotic resistance, However, given the rea-
sons stated above, none of these vaccines are expected to
provide full immunological coverage in a near future. It is
generally accepted that live-attenuated or avirulent
vaccines are suitable for inducing cell-mediated immunity
without affecting humoral immunity. Attenuated and/or
avirulent live S.suis strains have been tested, though the
results have been equivocal [10, 11]. This concern has
prompted exploration into alternative possibilities with bet-
ter therapeutic potentials against diseases caused by S.suis.
At present, the few known factors related to pathogen-
esis have not been found to induce global protection and
are of limited use. Comparing and analyzing genome se-
quences between virulent and avirulent strains of S.suis
2 may predict ORFs, specify unique genes and reveal the
presence of some previously uncharacterized genes pre-
dicted to involve in virulence and gene regulation. This
discovery will provide strategies for vaccine development
and new approaches in the prevention and treatment of
diseases caused by S.suis 2.
In this study, an avirulent S.suis 2 strain, designated
05HAS68, was isolated from a healthy pig in the Jiangsu
area of China. Genome analysis of strain should signifi-
cantly increase our understanding of different virulence
related genes and genomic islands of highly virulent
strains, 05ZYH33 and 98HAH33, which come from the
same affected areas. The genomic analysis will increase
our understanding the pathogenesis and evolution of
these strains. Using this information, we evaluated the
ability of the avirulent strain, 05HAS68, to provide
protective immunity against a challenge with S.suis 2
virulent strain, 05ZYH33, taken from a patient with
streptococcal toxic shock syndrome (STSS).
Methods
Bacterial strains and growth
A single-colony isolate of the S. suis 2 strain was
assigned the unique strain designation, 05HAS68. This
isolate originated from clinically-healthy pigs in theaffected areas of Jiangsu in China. This strain and the ref-
erence strain, 05ZYH33 were grown in Todd-Hewitt
broth (THB) (Difco Laboratories, Detroit,MI) medium or
and plated on THB agar plates containing 5% (vol/vol)
sheep blood at 37 °C.
Identification of Streptococcus suis serotype
Serotyping was performed by slide agglutination using
specific antisera (Statens Serum Institute, Copenhagen,
Denmark) and was positive for serotype 2. Briefly, 2 μl
of the broth was mixed with 8 μl of 0.1 M PBS (pH 7.4)
buffer containing 1: 500 diluted serotype-specific anti-
body or 3% BSA, incubated at room temperature for
30 min, and visualized at 400 × optical microscope.
Experimental infections of piglets
Three-week-old male specific-pathogen-free (SPF) - pig-
lets from the experimental animal center of Medicinal
Research Institute of Nanjing Military Command, were
divided into groups, six piglets per group, and were used
to evaluate protective effect tests and or specific T cells
transfer protective effect tests (6 piglets/group in
random). The avirulent strain 05HAS68 was used as the
experimental group and virulent strain 05ZYH33 and
98HAH33 was as positive control. All of the SPF piglets
were inoculated intravenously at a dose of 1.8 × 109 CFU
per piglet through the ear with different bacterial
suspensions. For the virulence studies, three groups of
piglets were directly injected with 05HAS68, 05ZYH33,
or 98HAH12, respectively. To evaluate the protective ef-
fect of 05HAS68, two groups of piglets were simultan-
eously inoculated with 05HAS68, and were given the
same dose of bacterial suspensions for booster on day 7.
Subsequently, these two groups were challenged with
05ZYH33 or 98HAH12 on 14. All animal experiments
were performed in a biosafety level 3 facilities and ap-
proved by the ethical committee of PLA Hospital No. 454.
Genome sequencing and comparative genomics
The 05HAS68 S. suis genome was sequenced and assem-
bled using the routine random shotgun method [12].
Prediction of putative coding sequences (CDSs) and gene
annotation were done using the NCBI’s Microbial Genome
Annotation Tools and Genome Annotation Pipeline
(http://www.ncbi.nlm.nih.gov/genome/browse/reference/).
The predictions and the slices were then searched against
the NCBI Entrez Protein Cluster database (https://www.
ncbi.nlm.nih.gov/proteinclusters/browse/stats/) as well as
proteins from all complete microbial genomes. The genome
sequence feature information was visualized using the
CGView genome visualization program ([13] http://stothar-
d.afns.ualberta.ca/). Annotation was supplied from both sets
and supplemented with information from the Conserved
Domain Database (https://www.ncbi.nlm.nih.gov/cdd) and
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of strains 98HAH33, P1/5 and 05HAS68 were compared
using FASTA3. The sequence alignment was produced by
Mauve Genome software [14] and the phylogenetic tree was
built using CLC Genomics Workbench 3.2 software
(https://www.qiagenbioinformatics.com/genomics/). Com-
parison of S. suis genome structures was done as follows:
pair wise comparisons of the P1/7, 05ZYH33 and
05HAS68 displayed chromosomes was done using the Ar-
temis Comparison Tool (ACT) [15, 16] and a dot matrix
was used to show the relatedness of genome sequences
generated with MUMmer [17]. The 05HAS68, 98HAH33,
05ZYH33 and P1/7 CRISPR defense systems were ana-
lyzed using CRT1.1 software [18]. Identification of the
bacterial CRISPR-associated proteins (Cas) adjacent to the
CRISPR loci and comparative analysis of proteins from
putative prophages, viruses (bacteriophage and viruses of
archaea), and plasmid-like sequences was done using the
Non-Redundant GenBank databases (https://www.ncbi.
nlm.nih.gov/genbank/).
Light and transmission electron microscopy (TEM)
To examine the strains morphological differences
between 05HAS68 and 05ZYH33, the methods were
performed according to our described previously [4].
The samples from agar-grown bacteria (05HAS68 and
05ZYH33 strain) were prepared by conventional
methods. Briefly, bacterial cell were fixed in 5% glutaral-
dehyde for 2 h, post fixed with 2% osmium tetroxide for
2 h, dehydrated in a graded series id acetone washes,
and embedded in Epon-812 epoxy resin. Thin sections
were post stained with uranyl acetate and lead citrate
and then examined with a JEM-1010 TEM (Jeol Ltd.,
Tokyo, Japan) at an accelerating voltage of 100KV.
Proteome analysis
The S. suis strains, 05HAS68 and 05ZYH33, were grown
at 37 °C in 400 mL THB, until they reached the mid-
exponential phase (OD600 0.8). The bacterial cells were
harvested by centrifugation at 5000 × g for 10 min and
washed with phosphate-buffered saline. Samples were
then homogenized on ice in 1 ml of lysis buffer (7 M
urea, 2 M thiourea, 4% CHAPS, 30 mM Tris-Cl, pH 8.5,
protease inhibitor mixture) using a glass homogenizer.
After sonication on ice for 10 s using an ultrasonic
processor, the samples were centrifuged for 30 min at
20,000 × g to remove particulate material. Aliquots
(280 μl) of the samples were loaded onto 13-cm
Immobiline DryStrip gels (pH 3 to 10; GE Healthcare
Biosciences Co.). The first-dimensional electrophoresis
conditions and second-dimensional sodium dodecyl
sulfate- polyacrylamide gel electrophoresis separation
were done as described previously. The separated pro-
teins were transferred to PVDF membranes byelectrotransfer. After transfer, membranes were blocked
with 1% w/v BSA in PBS (pH 7.4) for 1.5 h at room
temperature. The membranes were incubated with sera
taken from swine during the convalescent-phase of
05ZYH33 infection or from swine that had been vacci-
nated with 05HAS68. The sera (1:1000 dilution) was in-
cubated for 1 h at room temperature and subsequently
washed three times with 0.05% w/v Tween-20 in PBS for
10 min. Immunodetection was performed with Staphylo-
coccal Protein A-HRP (SPA-HRP, Boster; 1:1000 dilu-
tion) at room temperature. Before and after the addition
of the secondary antibody, the membranes were washed
three times with 0.05% w/v Tween-20 in PBS for 15 min.
The membranes were then washed with 50 mM Tris-
HCl buffer (pH 7.4) and developed with tetra
hydrochloride (DAB, AMRESCO) substrate until
optimum color development was observed.
To compare the abundance of protein spots on the
2-dimensional electrophoresis gels, the stained gels
were scanned and analyzed with an Image-Master in-
strument. Each protein spot was analyzed using
Malanie viewer 7 software (http://world-2dpage.expa-
sy.org/melanie/).
Lymphocyte preparation, culture and T cell adoptive
transfer
The lymphocytes were isolated from the heparinized
blood from SPF pigs vaccinated with the avirulent strain,
05HAS68. Briefly, lymphocytes (>85% purity) were pre-
pared by sequential centrifugation on Ficoll and Percoll
gradients. After isolation, cells (1 × 106 cells/ml) were incu-
bated with heat-inactive 05HAS68 cells (1 × 106 cells/ml) for
3 days at 37 °C in a 5% CO2 atmosphere. The specific T
lymphoblasts were prepared by sequential centrifugation on
Ficoll gradients. After washing, the cells were resuspended
in RPMI1640 and 1.8 × 109 cells or mixed with 5 ml plasma
from the piglets vaccinated with avirulent 05HAS68 and
were then transferred to naïve piglets (n = 6) via injection
into the ear vein.
TNF-α and IFN-γ quantification by ELISA
Plasma or sera from the pigs was collected following
centrifugation and stored at −80 °C until ELISA analysis.
TNF-α and IFN-γ was quantified using a swine
immunoassay kit (JINMEI BITECH, Beijing, China), as
specified by the manufacturer. Sample dilutions giving
optical density readings in the linear portion of the ap-
propriate standard curve were used to quantify the level
of each cytokine. Standard and sample dilutions were
added to duplicate wells on each ELISA plate, and all
analyses were performed at least three times for each in-
dividual stimulation assay. The A450 of the plates was
determined using a microplate reader (Thermo Scientific
Multiskan GO, USA). For all comparisons, was
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were performed using SPSS 11.0 for Windows
Statistical analysis
Quantitative results were expressed as the means ± SEM.
The data were analyzed using IBM SPSS Statistics 19.
The unpaired two-tailed Student’s t-test or Mann-
Whitney test was used to compare means between
different groups. One-way ANOVA with Bonferroni’s
post-test was considered appropriate for multiple com-
parisons. P-values less than 0.05 were considered
significant.
Results
Basic biological features
S. suis strain 05HAS68, isolated from a healthy pig was
identified by a quelling reaction and agglutination test.
The bacterial body of the 05HAS68 strain showedA a
D
C
B
05HAS68
05HAS68 + BSA
Fig. 1 Identified as S. suis serotype 2 using an agglutination test and the b
a. Strain 05HAS68 incubated with 3% BSA 0.1 M PBS as control; b. Strain 05
type 2 antibody. Comparison of basic biological characteristics between str
S. suis strains using Gram-staining. c Hemolytic phenotype of the strains on
cultured in THSagglutination and swelled after incubation with S.suis
type 2 capsular antiserum (Fig. 1a). This result indicated
that the 05HAS68 strain belongs to S.suis serotype 2. A
slight difference in growth was observed between the
virulent 05ZYH33 and avirulent 05HAS68 strains. The
05HAS68 strain grew at a slower rate than the 05ZYH33
strain in THB and the mean chain length of 05HAS68
was longer than that of 05ZYH33 under the same
growth conditions (Fig. 1b). Hemolytic analysis on sheep
blood agar plates indicated that 05HAS68 tends to in-
duce diminutive hemolytic zones, compared with
05ZYH33 (Fig. 1c). Similar capsular thickness was ob-
served between the 05HAS68 and 05ZYH33 strains
(Fig. 1d).
General genomic characterization
The strain 05HAS68 genome is a single, circular
chromosome of 2,188,363 bp (Fig. 2a) with a GC contentb
05ZYH33
05HAS68 + specific antisera 
iological features of 05HAS68. a Strain 05HAS68 serotype identification
HAS68 incubated with coagglutination reagent of specificanti-capsular
ain 05HAS68 and 05ZYH33 (b-d): b), Light microscope morphology of
blood agar plates. d Transmission electron micrographs of bacteria
AB
C
E
F
D
Fig. 2 (See legend on next page.)
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Fig. 2 Circular representation of the 05HAS68 genome and in silico comparisons between S. suis genomes. a The outer circle shows the scale
(bp). From in to out indicate that circle 1: GC-skew (blue: > 0; light coral: < 0), circle 2: G + C content (avg = 41%), circle 3: duplicated genes, circle 4:
colinear blocks (blue: unique to strain68; purple: colinear with strain05), circle 5: unique genes (inner: on plus strand; outer: on minus strand), circle
6: gene density (avg = 85%, win_size = 5 kb; blue: below avg level; red: above avg level), circle 7: cds (color: see COG legend; inner: on plus strand;
outer: on minus strand), circle 8: coordinates. b The 05HAS68, 98HAH33, and Sanger protein sets were compared using FASTA3. Numbers under the strain
name indicate genes that are not shared with the other strains; values in parentheses are the number of proteins in each strain (excluding frame shifted and
degenerated genes). Numbers in the intersections indicate genes shared by two or three strains. These are displayed in the color corresponding to the strains
used as the query. Numbers in any given intersection are slightly different due to gene duplications in some strains. c Phylogenetic tree of S.suis serotype 2
strains based on genomic sequences. The CRISPR antiviral system of 05HAS68 (d) and 89/1591 (e). f Two-dimensional gel electrophoresis profile of silver
stained whole-cell proteins from S.suis 2 strain 05HAS68 (a) and 05ZYH33 (b) grown to the mid-exponential phase. In the 3D image displayed, the important
virulence proteins EF, MRP and SYL are indicated by color arrow grey, black and white
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all 3 genomes. Strain 05HAS68 shares 32 genes (1.7%)
with 98HAH12 and 26 genes (1.4%) with P1/7. Finally,
275 genes (14.7%) are unique to 05HAS68 (Fig. 2b).
Except the 89 K large insertions in 05ZYH33 and
98HAH33, few differences were found in virulent
strain P1/7 that has been reported by us. The
05HAS68 genome is similar in size, number of open
reading frames (ORF), GC content, gene length and
density to strains 05ZYH33 and 98HAH33, which
were sequenced by our lab 2 years ago. However, the
order of genes and genome fragments, gene compo-
nents and a number of the CDS are quite different
compared to the virulent strain (Table 1). Further-
more, the capsule plays an important role in virulence
and dividing serotypes and 14 genes that controlTable 1 Genome features of 05HAS, 05ZYH33, 98HAH12 and P1/7
Feature Genome
05HAS68
Length of sequence(bp) 2,188,363
G + C content 41.18%
Repeat content length (%) 9032(0.41%)
Simple repeats length(coverage) 411(0.02%)
Low complexity length(coverage) 1903(0.09%)
Repeat element length 659
Small RNA #(length, coverage) 30(6, 059, 0.28%)
ORF (Length in Genome) 1,861,062
Feature
ORF # 1874
Genome coverage (%) 85.04%
Genome density (genes/Kb) 0.86
Average gene length (bp) 993
Max gene length (bp) 7272
Function
ORF with assigned functions 1741
Conserved hypothetical protein 83
ORF without database match 50capsular biosynthesis were found to be identical be-
tween 05HAS68, 05ZYH33, 98HAH33 and P1/7.
Two-component gene regulatory systems (TCSs) have
been well studied in many pathogenic bacteria and are
known to regulate expression of many key virulence
factors, such as extracellular toxins [19–23]. The two ge-
nomes of the S.suis 2 Chinese virulent strains, 05ZYH33
and 98HAH33, have 15 of the same conserved TCSs. Ex-
cept that two of them are located in the specific 89 K
GEI of the Chinese virulent strains [12], are the same as
those in strain P1/7. However, only nine of 15 TCSs
were found in the avirulent strain, 05HAS68 (Table 2).
The results of sequence and proteomic analysis indicated
that some major putative virulence factors, such as EF
and SLY, are absent in strain 05HAS68 (Table 3, Fig. 2f ).
Analysis of the virulence factor MRP, in both strains05ZYH33 98HAH12 P1/7
2,096,309 2,095,698 2,007,491
41.11% 41.11% 41.30%
9605(0.46%) 9357(0.45%) 0.43%
351(0.02%) 243(0.01%) 284(0.01%)
2339(0.11%) 2330(0.11%) 1927(0.10%)
612 706 323(0.02%)
30(6, 303, 0.30%) 30(6, 078, 0.29%) 28(6053, 0.30%)
1,766,700 1,771,236 1,726,753
1824 1836 1719
84.28% 84.52% 86.02%
0.87 0.88 0.86
969 965 1005
6822 5910 6285
1801 1809 1594
16 20 95
7 7 30
Table 2 Analysis of virulence-associated genes from 05HAS68
and 05ZYH33 strains
Function category Gene name
05HAS68 05ZYH33
Adherence/Colonization factors
Fibrinogen binding protein (fbp) PSN_CDS03155 SSU05_1492
PSN_CDS01399 SSU05_1663
Muramidase-released protein (mrp) PSN_CDS00463* SSU05_0753
Agglutinin receptor PSN_CDS02376 SSU05_0965
Adhesin PSN_CDS04016 SSU05_2068
PSN_CDS00076 SSU05_0112
PSN_CDS00520 SSU05_0330
Autotransporter adhesion PSN_CDS00785* SSU05_0474
Cell surface factors
Extracellular protein factor (ef) - SSU05_0177
- SSU05_0178
Exotoxins
Hemolysin III homolog PSN_CDS02424 SSU05_0994
Putative hemolysin PSN_CDS01385 SSU05_1668
PSN_CDS01413 SSU05_1653
Suilysin - SSU05_1403
Siderophores
ABC-type Fe3+ siderphore transport system
Permease component PSN_CDS03427 SSU05_0646
PSN_CDS03424 SSU05_0647
ATPase domain PSN_CDS02486 SSU05_1031
ATPase component PSN_CDS03419 SSU05_0650
Miscellaneous
Tetracyline resistance protein (tetM) PSN_CDS02364* SSU05_0922
*The gene is largely mutated
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tide prediction, showed a large number of mutants on
amino acid sequences and antigenic epitopes (Additional
file 1: Figure S1).
Since it is hard to find the real ancestor of S.suis 2, the
last common ancestor (LCA) of the S.suis genome was
reconstructed by identifying the homologous genes
among the 05ZYH33, 98HAH33, 05HAS68, P1/7 and
89/1591 strains, and assuming that the genes of the LCA
were still present in at least two strains and that the spe-
cial genes in each strain were genes, which were gained.
The genes were included in order to construct the LCA
genome and to study evolutionary phenomenon, such as
rearrangement, duplication, and gain or deletion in each
ongoing genome based on the available information,
though this arbitrary classification cannot produce the
exact genome. In total, 1920 orthologous clusters (ORs)
were obtained in these five strains, and cumulative study
showed that about 37 orthologous genes may have beenreduced with the addition of more strains (Fig. 2b, Add-
itional file 1: Table S1, Table 2). The actual gene number
may vary in different strains due to gene duplication.
Compared to the LCA, the five strains were missing 192,
181, 223, 235, and 434 ORs, but had added 80, 336, 121, 9,
and 155 genes. To evaluate the relationships among
strains, a dendrogram was constructed based on noncore
genic differences. As expected, strain 05HAS68 and strain
89/1591 from North America, was the most closely re-
lated pair (Fig. 2c).
The clustered regularly interspaced short palindromic
repeat (CRISPR) presents an interesting genetic marker
for comparative and evolutionary analysis of closely
related bacterial strains [24, 25]. Analysis of the S.suis 2
05HAS68 complete genome sequence revealed a locus
of 1767655–1768150 bp, having a typical CRISPR
organization: eight repeats of 36 bp, separated by unique
sequence spacers of 30 bp. A clustering of the cas1, cas6
and cas7 genes (stc: str0658, str0659 and str0660) was
localized upstream of the locus. A leader sequence,
which contained an AT-rich sequence, was located 5’to
the CRISPR loci, directly adjoining the first repeat
(Fig. 2d). A similar structure was found in contig 269 of
89/1519 (gi|80977822|gb|AAFA02000001.1|), though
one repeat of 36 bp was absent (Fig. 2e). CRISPRs were
not found with CRISPR recognition tool (CRT) when
examining strains 05ZYH33, 98HAH33 and P1/7 [18].
Genome feature with large scale arrangement
Whole-genome alignments of 05HAS68 with 05ZYH33
or a Sanger P1/7 display included all commonly used
rearrangement operations that affect a permutation, in-
cluding reversals (also called inversions), transpositions,
and block interchanges (i.e., generalized transpositions).
Large chromosomal rearrangements, including both in-
versions and translocations and at least seven large in-
versions rearrangement locations were observed, when
comparing 05HAS68 to the 05ZYH33 and P1/7 strains.
These inversions seemed to create an “X-shaped” like
alignment, which likely resulted from chromosomal in-
versions that pivoted around the origin and terminus
many times (Fig. 3a). However, in the S.suis serotype 2
strains, the devil of account genes from phages, but no
useful information was acquired to hint that contain
prophage in these strain chromosome with prophage
prediction software phage finder [26], except a few
transposases local in these fragment upstream or down-
stream such as on sequence of 05HAS68 chromosome
site at bases 630703 to 788878 (IS111A), bases 868905
to 920358 (IS204) or bases 1772301 to 1887337. Despite
numerous rearrangements and IS elements, the
05HAS68 genome has remained remarkably stable dur-
ing over a period of 2 years of cultivation in vitro (data
not shown).
Table 3 Two component signal transduction systems identified in the genome of different S. suis 2 strains
TCS Predicted function Demonstrated
role in virulence
of S. suis2
S. suis2 strain
05ZYH33 98HAH12 05HAS68 P1/7
LiaS/LiaR Cell wall Stress response,
antimicrobial resistance
No 1 1 1 1
NisK/NisR Lantibiotic production No 1 1 - -
SalK/SalR Lantibiotic production Yes 1 1 - -
CiaH/CiaR Competence and antibiotic
susceptibility
No 1 1 1 1
YycF/YycG Essential for growth No 1 1 1 1
YxdK/BecR antimicrobial resistance No 2 2 2 2
VanR/VanS Vancomycin resistance No 1 1 1 1
YocF/YocG Thermosensing No 1 1 1 1
CsrR Virulence Yes 1 1 1 1
YesM/YesN Unknown No 1 1 - 1
Orphan rr of the LytR family Regulation of murein
hydrolase activity
No 2 2 1 2
RevS Virulence Yes 1 1 - 1
VirS/VirR Virulence Yes 1 1 - 1
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genomes differed in their DNA sequences, suggesting
that they were acquired (and then often degraded) after
separation of the bacterial lineages. However, at the
DNA sequence level the genomes could still be aligned
over essentially the entire chromosome (data not
shown).
Structural characterization of a GEI
We previously reported that a candidate GEI of ~89 kb
in length, which is related to virulence, was investigated
at the genomic level [12]. This GEI was found to be site-
specifically integrated in the 3’ end of the ORF L7/12 of
S.suis 05ZYH33 and 98HAH33. This was compared with
a strain very closely related to P1/7, which does not
carry any element integrated in the 3’ end of L7/12. As
one novel type GEIs, they contain 15 bp (TTATTTAA-
GAGTAAC) insertion sequence (IS), which was present
in 5’ terminal of highly conserved gene L7/L12. This in-
teresting mosaic structure suggests that this region of
the genome is a hot spot for lateral GEI transfer. The
franking 89 kb genomic island from this IS element in
the chromosome of S.suis 2 strains 05ZYH33 and
98HAH33 was noticeable. The IS element also emerged
in the 89/1591 strain genome. Since the genomic se-
quence of strain 89/1591 is unfinished, a novel genomic
island, named 55 k, was predicted and assembled from
four contigs (gb: AAFA02000004.1, gb: AAFA02000007.1,
gb: AAFA02000008.1, gb: AAFA02000134.1). Comparing
and mapping this IS element between strains 05ZYH33
and 05HAS68 showed that a large 112 k DNA fragment
was inserted in the hot spot. In these regions, G + Ccontent differ significantly from that of the overall G + C
content of the host chromosomes (Fig. 3b). Besides frank-
ing the fragment, one of the IS elements was located in
the 112 k fragment and divided it into 48 k and 64 k. This
result suggests a potential tandem integration of GEIs.
GEIs 89 k, 112 k and 64 k have identical features, which
were found to be integrated at the 3’ end of the chromo-
some L7/L12 gene, presented integrase at 3’ terminal and
replication initiator A at 5’ terminus of the GEI and mo-
saic structures of several individual acquisitions (Fig. 4).
As previously reported, the 89 k GEI carries some genes
or gene clusters expressing virulence related proteins and
regulators [12] and the 48 k GEI carries a novel system re-
sponsible for L-fucose metabolism and the 64 k genetic
loci encodes galactose metabolism. Both the 48 k and 64 k
GEIs carry two components (VirB4 and VirD4, respectively)
from the type IV secretory pathway. Analysis of the 48 k
GEI construct showed that it was truncated to lose the rep-
lication initiator A gene at the end of the 5’ terminus.
Evaluation of protective immunity of a piglet against S.
suis strain 05ZYH33
Piglets were vaccinated with either the 05HAS68 or
05ZYH33 strain or were used as a control. After two
vaccinations given intravenously, via the ear vein, the
piglets were challenged with 1 × 108 CFU of the
05ZYH33 virulent strain administered intraperitone-
ally (i.p.). All of the piglets (100%) immunized with
the 05HAS68 avirulent live vaccine strain survived,
whereas 100% of unvaccinated control piglets died
after challenge with 05ZYH33. The time to death/sur-
vival ratio of piglets immunized with the strain
AB
Fig. 3 Whole-genome alignments between the P1/7 and 05ZYH33 strains with the 05HAS68 strain are shown by using MUMmer or ACT. a
Dotmatch analysis in MUMmer. 05HAS68 or 05ZYH33 genome sequnce was plased X or Y axes. The red dot indicates that the match DNA
sequence is in the same direction and the blue dot indicates the opposite direction. b The G + C content of genomes are shown by 20000-bp
sliding window plot and the thin grey line tracing the average G + C content
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that of nonimmunized piglets (Fig. 5a).
A 2-D Western blot approach was used to compare and
visualize the reaction of the whole 05ZYH33 bacteria prote-
ome to swine sera from convalescent-phase piglets with
05ZYH33 infection or piglets vaccinated with 05HAS68.
After vaccination in the field trial, the same specific anti-
bodies against the 05ZYH33 strain were induced and com-
pared with the convalescent phase 0f 05ZYH33 infection
except with anti-EF, MRP and SLY (Fig. 5). The Wilcoxon
signed ranks test was used to analyze the level of serumspecific IgG to S.suis in anterior-posterior vaccination
05HAS68. The result showed that the level of anti-S.suis
specific IgG in serum from piglets vaccinated with
05HAS68 was significantly increased P (Z) < 0.05. The re-
active IgG titers were more than 1: 5000.
The plasma levels of TNF-α and IFN-γ, TNF-α and IFN-
γ were not significantly raised (p < 0.05) 2 days after vaccin-
ation with the 05HAS68 strain. Compared with naïve
piglets, the levels of TNF-α or IFN-γ in the peripheral
blood of 05HAS68 vaccinated piglets challenged with
05ZYH33 were significantly increased (p < 0.01) (Fig. 6).
Fig. 4 Analysis of site-specific genomic island. Colored column represents gene homologues. Green = RPL7/12, black bar = 15 bp repeat sequence,
red = integrase, blue = replication initiator, blue = 89 k, violet = 2-component signal transduction systems, histidine kinase (deep) and DNA binding
regulatory protein (light)
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Active specific T cells were obtained from the peripheral
blood of piglets, from fraternal multiple births that was
vaccinated with the live 05HAS68 avirulent strain, and ac-
tivated via heat inactivation in vitro. These T cells were
then transferred to 05ZYH33-infected piglets. The results
showed that these T cells could significantly delay the timeFig. 5 Comparison of whole-cell proteins extracted from S.suis 2 strain 05Z
pigs in the convalescent-phase, which had been clinically infected with the S
and SLY proteins are indicated by red, yellow and green arrowsof death (48–72 h) in the 05ZYH33-infected piglets. Inter-
estingly, the results in piglets injected with the mixture of
these T cells and plasma from an immunized animal were
similar to those observed in vaccinated piglets, which sur-
vived without any obvious clinical symptoms until the end
of the experiment (14 days after infection with the
05ZYH33 virulent strain, Fig. 7b).YH33 by 2-dimensional Western blotting using anti-sera pooled from
.suis 2 strain 05ZYH33 (a) or vaccinated with 05HAS68 (b). The MRP, EF
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Fig. 6 Level of cytokine IFN-γ and TNF-α from different phases of plasma: Group A indicates the cytokine value from naïve piglets. Group B and C
indicates cytokine values from plasma after 48 h after vaccination with strain 05HAS68 or from piglets (n = 6) that had been vaccinated twice with
strain 05HAS68 and then challenged by an intravenous injection of virulent strain 05ZYH33 2 days later. Values are arithmetic means ± standard
errors of the means. *, P < 0.05; **, P < 0.01
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Chinese isolates of highly pathogenic S.suis 2 caused two
recent large-scale human epidemics and caused a large
number of pig deaths in China. The mechanisms involved
in the pathogenesis and virulence of S.suis 2 are notA B
Fig. 7 Observed survival time of piglets. a Protection induced by
vaccination of piglets with the live avirulent S.suis serotype 2 strain
05HAS68. (a) and (b) The piglets were challenged intravenously with stain
05ZYH33 and 98HAH12 as positive control.; groups (c) and (d) on day 7
after vaccination with 109 colony forming unit (CFU) of avirilent 05HAS68,
the piglets were injected with the same bacterial concentrations of
05ZYH33 or 98HAH12, separately; (e) The piglets were injected only with
stain 05HAS68 as negative control. b Observed protection by transfer of
active specific T cell against S.suis to thepiglets (4 piglets/group). (a) The
piglets were challenged intravenously with stain 05ZYH33 as positive
control; (b) the piglets were transfused intravenously active specific T cell
(1.8 × 109 cells) from the piglets were vaccined with stain 05HAS68 or (c)
active specific T cell (1.8 × 109 cells) and plasma (5 ml) mixture from the
piglets were vaccined with stain 05HAS68; (d) the piglets were transfused
intravenously T cells (1.8 × 109 cells) and plasma (5 ml) mixture from
healthy naïve piglets as negative controls. Each data point represents
one pigletcompletely understood. Attempts to control the infection
have been hampered by lack of an effective vaccine. The
identification and characterization of a potential live aviru-
lent vaccine is one of the strategies and prerequisites for
development of an effective vaccine.
At least 10% of swine in Germany carry an S. suis
strain [27], and it is likely that the percent is higher
in China. As the most prevalent among the invasive
porcine and human isolates, the complete genome
sequences from a few virulent S.suis 2 strains have
been reported, including P1/7, 89/1591, 05ZYH33 and
98HAH33; however, the characterized genomes of
avirulent strains, which comprise the overwhelming
majority of S.suis 2 strains, are almost completely
unknown.
The current study reports on an avirulent S.suis 2
strain, 05HAS68, which has similar basic biological
features as Chinese isolates of highly pathogenic S.suis
2, with the exception of hemolytic activity in vitro.
Proteome detection indicated that the 05HAS68 strain
lacks some major putative virulence factors, such as
EF and SLY. MRP as an important virulent factor,
compare the amino acid sequences of MRP from
strain 05HAS68, P1/7, 89/1591, and 05ZYH33, the
protein from strain 05HAS68 and 89/1591 emerge
large mutant. Analysis and prediction suggest that
this mutant causes a change of potential biological
function and antigenic epitopes. Analysis of the
05HAS68 genome indicates that it lacks six of 15
TCSs compared with the 05ZYH33 strain. At least
three of the missing six TCSs relate to the virulence
of S.suis 2. Comparing the genic contents of the five
strains suggests that the total number of pan-genes in
the S.suis 2 species is around 3880 and the total
number of core genes is around 1290. The pan-
genome size of S.suis 2 has not been estimated very
well since only five sequences are currently available.
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than 70% of all core-genes were conserved among all
strains. When the genomes of individual strains were
evaluated, 15 to 35% of the core-genes were noncore.
Strain 05HAS68 and the typical North American viru-
lent strain, 89/1591, belong to one branch of the non-
core genes tree and strains 05ZYH33 and P1/7 are on
another branch. This suggests that strains 05HAS68
and 05ZYH33 are different than the most recent
common ancestor.
Previous research presented a comparative genomics
approach to assess levels of recombination and
positive selection pressure in the core-genome and
pan-genome size for each of the Streptococcus taxo-
nomic groups. The results suggested that Streptococcus is
the greatest positive selection pressure, has the largest
number of loci uniquely selected, and the lineage that had
the greatest amount of gene gain and loss. This positive
selection pressure means that S.suis 2 is likely to shuttle
back and forth between pig and human hosts. We
certainly concur with these authors that much of gene
gain and loss of S.suis 2 likely reflects species-specific
adaptation [5].
Comparing present genomes to the ancestor genome re-
veals clues to their virulence and environmental adapta-
tion via four major evolutionary paths including genome
rearrangement, deletion, duplication and horizontal gene
transfer. The flexibility of genomes and examples of DNA
rearrangement and their roles in gene regulation have
been documented in different prokaryotes [28–30]. The
whole-genome alignments between P1/7, 05ZYH33 and
05HAS68 displayed numerous DNA fragment inversions
and transpositions in their chromosomes. The DNA rear-
rangements altering gene expression has been reported
[29]. These inversions and transpositions chequered with
S.suis 2 strains whether change the expression of virulent
or relate genes, which deserve our further study… Previ-
ous studies from our laboratory, using two genomic se-
quences (05ZYH33 and 98HAH33) from clinical strains,
identified novel genes that are not present in the Sanger
P1/7 strain and suggested a GEI insert in the chromo-
some. In the current study, the genomes of four S.suis 2
strains were analyzed, and a similar GEI structure was
found in strains 05HAS68 and 89/1591. Numerous
integrative elements (e.g., prophages and/or integrative
conjugative elements) integrate into the 3’ end of genes
encoding tRNAs, though their sequences remain unmodi-
fied by the integration. Other integrative elements (e.g.,
most of the conjugative transposons) integrate into several
or numerous sites [31]. Only a few elements site-
specifically integrate into the 3’ end of protein-encoding
genes. The substitution sequence is then generally only
similar to the original one [28]. Similar to one novel type
GEI, these sequences insert into a chromosome by site-specific integration at the 3’ terminal dependent 15 bp dir-
ect repeat sequence of an L7/L12 gene and require a func-
tional integrase gene. It is very interesting that these
similar GEIs carrying gene clusters, which are very differ-
ent in function. A few of the strain-specific genes are
in the 89 k GEI, although they do not show the clas-
sical features of pathogenicity islands, are flanked by
insertion elements and display an atypical nucleotide
composition, suggesting possible acquisition through
horizontal transfer for adoptive evolutionary response
to new hosts. Our current knowledge of the impact
of mobile genetic elements, as GEIs, in their hosts
comes primarily from pathogenicity islands in which
bacteriophages, plasmids and transposons act as car-
riers of genes encoding toxins, effector proteins, cell
wall modification enzymes, fitness factors, and anti-
biotic and heavy metal resistance determinants in
pathogenic bacteria. Much less is known about the di-
versity and role of GEIs in nonpathogens, in which
these elements may enable their hosts to adapt to
changing environmental conditions or colonize new
ecological niches [32]. As avirulent bacterium colonize
in the nasopharynges of healthy pigs only, the
05HAS68 genomic 48 k GEI carries a novel L-
fuculose metabolic system in S.suis 2 to adapt to this
environmental parameter and the 64 k GEI carries a
homeo-gene cluster, which is a classical lactose me-
tabolism system. The 48 and 64 k GEI of strain
05HAS68 couple and assemble a larger 112 GEI. As
the 48 k construct emerged it was truncated and lost
the replication initiator A gene at the end of the 5’
terminus. It has been suggested that the 112 k con-
struct evolved by site-specific accretion from a com-
posite structure of GEIs. Although the 112 k GEI from
avirulent strain 05HAS68 exhibits a partial similarity to 89
and 55 k GEIs from virulent strains, the virulent strains also
carry large niche-specific genes that could putatively affect
the survival of strain 05HAS68 in natural habitats. In
addition, when strain 05ZYH33 were repeatedly inoculated
and cultured for a long time in THB medium, the 89 k GEI
was lost from the chromosome and the circular 89 k DNA
was detected in the cells [33]. This supports a general hy-
pothesis that GEI contributes to host fitness. Under the
same culture conditions, a loss of 112, 48, or 64 k GEI has
not been observed in the 05HAS68 strain. Possible reasons
are either that the cells cultured in THB had some similar-
ities with their primary habitat or that fitness was not lost
due to interference by the CRISPR defense system; however,
the reason(s) are not fully understood.
Indeed, to date, no successful vaccine against S.suis
has been produced and heat-killed bacterial preparations
have failed to induce protection. Because S.suis 2 com-
mands such a large genic diversity, it is almost impos-
sible to depend on 1 or even several virulence factors
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logical protection for each of the S.suis 2 pathogenic
strains. The heat-killed bacteria can be quickly cleaned
by phagocytes and are not enough to induce specific im-
munological protection. In the current study, the live
cells of the avirulent strain, 05HAS68, could be used for
the immunization of swine, the natural host. It was com-
pletely cleared in the peripheral blood of the host until
about 30 h, and thus had enough time to induce specific
immunological protection. Recent studies suggest that
the leading vaccine candidate, which primarily stimulates
antibody-mediated humoral immunity, may not suffice.
T cell-dependent cellular immunity comprises a second
means by which vaccines prime long-lived protection
against virulent bacterial pathogens [34].
Our results showed that the high titer IgG serum from
piglets immunized against the avirulent strain could
recognize most proteins of the tested virulent strain.
Analysis of cytokines in the serum after 05HAS68
vaccination and 05ZYH33 challenge indicated that the
levels of TNF-α and IFN-γ were significant increased. It
has been reported that CD4 responses are associated
with strong cell-mediated inflammatory responses,
which may be favorable for pathogen elimination from
the host [35]. The CD4 T cell is a major cellular source
of TNF-α and IFN-γ. Mice lacking IFN-γ have been
shown to be more susceptible to pneumococcal infection
and administration of IFN-γ can enhance survival of
mice after pneumococcal challenge [36, 37]. However,
TNF-α is a double-edged sword; it is a proinflammatory
cytokine that can promote protective immune responses
against a variety of pathogens, but may also cause in-
flammatory host injury under certain conditions [38].
This study found that co-transference of active T cells
and plasma from pigs of vaccinated with strain 05HAS68
provided global protection to pigs challenged with the
05ZYH33 virulent strain; however transferring one of the
two were insufficient for providing immunological protec-
tion. This result suggests that plasma contains specific
antibodies and that the bactericidal activity of T cells
against S. suis is very important, because T cell immunity
may also provide antibody-independent protection against
S.suis 2 infection. Results of this study suggest that a naïve
avirulent live cellular vaccine that promotes both humoral
and cellular immunity will most effectively combat the
highly virulent 05ZYH33 strain and has important impli-
cations for the development of an effective vaccine to pro-
tect pigs against S. suis infection.
Conclusion
In conclusion, comparison of S.suis 2 genomes showed
massive scale arrangement, which can potentially alter genes
expression, an enormous amount of single gene gain and
loss, and GEIs that carry different functional gene clusterinserts for S.suis 2 species. As S.suis 2 has the largest genic
diversity, it is almost impossible to depend on using one or
even several virulence related substances as vaccines to in-
duce global immune protection for all S.suis 2 pathogenic
strains. In view of these results, that specific protection was
induced from humoral and cellular immunity via vaccin-
ation with the avirulent strain, 05HAS68, it is suggested that
research strategies for vaccine design and development be
reconsidered using model strains for testing.
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